To identify novel lincRNAs, RNA-seq reads were first mapped to the human reference genome version hg19 using Tophat (version 2.0.13) [1] with default parameters. Only uniquely mapped reads were retained. Cufflinks (version 2.2.1)[2] was used to assemble aligned reads into transcripts, based on which we developed a method to identify novel lincRNAs. In details, we retrieved unannotated transcripts and mapped their exons (termed query exons) to the human reference genome to calculate the exon coverage of each base. In order to obtain a unified exon set, we defined two parameters including ceiling coverage and floor coverage, representing the upper and lower limits of exon coverage, respectively. Initially, putative exons were identified as genomic regions with exon coverages of all bases in them no less than the given ceiling coverage value. Then we compared each putative exon with query exons. If a putative exon satisfied three criteria: 1) the overlap with a query exon must account for ≥ 80% of the query exon; 2) the overlap with a query exon must account for ≥ 50% of the putative exon; 3) the number of query exons that satisfy both 1) and 2) must be more than the given ceiling coverage value, the putative exon was retained as a component of the unified exon set. Through iterative searches of putative exons with different coverage (ranged from ceiling coverage to floor coverage), a final unified exon set was constructed. Different values of ceiling coverage and floor coverage can be used to identify unified exons with different resolutions. In this study, both ceiling coverage and floor coverage were set to 8. Subsequently, unified exons were assembled into transcripts and we considered the ones with length ≥ 200bp and coding potential score (calculated by CPC tool) ≤ 0 as novel lncRNAs.
we detected significantly differentially expressed lincRNAs in three contexts -comparisons between SZ cases and controls in BA24 (BA24_SZ for short) and BA9 (BA9_SZ for short) and comparisons between BD cases and controls in BA11 (BA11_BD for short), we constructed co-expression networks for these contexts. For each context, the FPKM values of filtered lincRNAs and PCGs (read count>2 in more than 50% samples) were normalized by log2 transformation (i.e. log2(FPKM+1)) and quantile normalized, then Pearson correlation coefficients were calculated for all gene pairs. The resulting correlation matrix was transformed to an adjacency matrix using a power function. A scale-free topology criterion [4] was adopted to choose the power (10, 9 and 5 for BA24_SZ, BA9_SZ and BA11_BD, respectively). Based on the adjacency matrix, topological overlap (TO, indicating relative interconnectedness between two genes) was calculated for each pair of genes. Then, modules were detected using average linkage hierarchical clustering based on the TO dissimilarity (1-TO). The minimum module size was set at 30 genes and the minimum height for merging modules at 0.25 for BA24_SZ and BA9_SZ, while minimum height of 0.15 was chosen for BA11_BD to obtain moderately large and distinct modules.
Identification of significantly co-expressed modules
To verify genes in the modules were co-expressed beyond by chance, we performed permutation test based on the assumption that the mean TO of a network module should be greater than that of a random module [5] . For each module, we randomly selected 100 sets of genes with equivalent size of the module from the network. The p-value was estimated as the ratio of random gene sets whose mean TO was greater than that of the module. Then, multiple comparison correction was performed for all modules in a network. Finally, modules with FDR<0.05 were considered significantly co-expressed modules.
Module characterization
Enrichment of DELincRNAs or DEPCGs in the significantly co-expressed modules were assessed using hypergeometric test with FDR<0.05. The modules which contained lincRNAs and were enriched with DELincRNAs or DEPCGs were retained for subsequent analyses.
Over-representation of brain-related markers were performed using the WGCNA function userListEnrichment with Bonferroni corrected p-value<0.05. Correlation test between module eigengenes (equivalent to the first principal component [6] ) and clinical traits such as diagnosis, age, sex, race, PMI and brain PH were performed using corPvalueStudent function.
Disease-associated modules were identified as those showing significant correlation (p-value<0.05) with disease state while non-significant correlation with other clinical traits.
To identify potentially disease-causal modules, we utilized the method described in [7] to perform gene-set-based GWAS enrichment analysis. Summary results of association of SNPs with SZ or BD were retrieved from [8, 9] , respectively. For each gene in a given module, we assigned SNPs within 110 kb upstream and 40 kb downstream to it. We counted the number of SNPs (N) assigned to all genes in each module. Then we determined the proportion of SNPs with nominal association p-values<0.05 in the module. Next, we randomly selected N SNPs from GWAS data with replacement and calculated the proportion of SNPs with GWAS p-value<0.05. We repeated random selections 10000 times and the p-value of GWAS enrichment in a module was determined as the ratio of random selections whose proportion of nominally significant SNPs was greater than that of the given module. Finally, FDR correction was performed to identify modules with significant SZ-or BD-associated GWAS signal enrichment.
Epigenetic analysis

MeDIP-seq analysis
Methylated DNA immunoprecipitation and sequencing (MeDIP-seq) of 6 SZ patients and 6 controls was performed as previously described [10] . Briefly, DNA was collected from BA24 of samples and then fragmented by sonication to a mean size of approximately 250 bp, followed by end-blunting, dA addition to the 3'-end and ligation of adapters. After PCR amplification, DNA fragments were subjected to 50 bp paired-end sequencing using Illumina HiSeq2000. After quality control, raw reads were aligned to human reference genome hg19 using bowtie (version 1.1.1) [11] with two mismatches. Only the nonredundant, uniquely mapped reads were retained for subsequent analysis.
To quantify the methylation levels of lincRNA, MeDIP-seq data of BA24 was processed using MEDIPS package (version 1.12.0) [12] . Specially, the relative methylation score (rms) was calculated with a sliding window of 250 bp. Then the absolute methylation score (ams) which was corrected for CpG density was calculated for each DELincRNA in each sample through dividing mean rms by mean coupling factors of bins that located in the promoter (-2 to 0.5 kb from TSS).
Differential methylation was calculated using Wilcoxon rank sum test among 35 DELincRNAs. A lincRNA was defined as significantly differentially methylated if P-value<0.05.
ChIP-seq analysis
ChIP-seq data for histone marks H3K4me1, H3K4me3 and H3K27ac of BA24 were obtained from the NIH Roadmap Epigenomics Program [13] (GSE17312). A lincRNA was defined as an enhancer-associated lincRNA (elincRNA) if its promoter was significantly enriched for H3K27ac peaks calculated by MACS [14] (P-value<0.05).
